Biotech Generative AI Open Source 
TechCrunch
SEPTEMBER 14, 2023
Proteins, the natural molecules that carry out key cellular functions within the body, are the building blocks of all diseases. Characterizing proteins can reveal the mechanisms of a disease, including ways to slow it or potentially reverse it, while creating proteins can lead to entirely new classes of drugs and therapeutics.
CIO
APRIL 17, 2024
The retail industry has no shortage of cases on display where generative AI has shown tangible benefits. They had ChatGPT write the script, and other gen AI tools to create a digital person who reads the script, a scalable process with at least one measurable benefit: speed. And software code is a language.”
Crunchbase News
JUNE 4, 2024
Not surprisingly AI led the way — as it always seems to do — with a trio of a billion-or-more rounds. xAI , $6B, artificial intelligence: Elon Musk ’s generative AI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generative AI company in the world behind only competitor OpenAI.
TechCrunch
AUGUST 18, 2023
We featured generative AI companies five years before the popular investors took notice and climate tech 2.0 Clean tech – Tied in with the biotech trend, we’re seeing a continued surge in input/output companies that process waste to produce byproducts like energy and potable water. It’s a big new data rush.
Crunchbase News
AUGUST 23, 2024
Investors certainly put their money everywhere, from biotech to productivity tools, but they didn’t shell out a lot. Grafana’s open-source software platform helps monitor and visualize data. Pathalys Pharma , $105M, biotech: Raleigh, North Carolina-based Pathalys Pharma isn’t new to this list — it topped it early last year.
Crunchbase News
SEPTEMBER 4, 2024
You had to raise more than $150 million to make the top 10 list this month — as investors put money into everything from defense tech to semiconductors to biotech. GondolaBio , $300M, biotech: BridgeBio Pharma spun off GondolaBio this month, a biotech focused on early-stage genetic disease treatments.
Crunchbase News
MARCH 15, 2024
The company leverages generative AI in developing software to help customers create driver-assistance systems and automated driving solutions. Zephyr AI , $111M, biotech: Mclean, Virginia-based healthcare startup Zephyr AI closed a $111 million Series A from investors that included Revolution Growth and Eli Lilly & Company.
Expert insights. Personalized for you.
327 
Let's personalize your content